<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144620">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01910285</url>
  </required_header>
  <id_info>
    <org_study_id>12 522 03</org_study_id>
    <secondary_id>HAO</secondary_id>
    <nct_id>NCT01910285</nct_id>
  </id_info>
  <brief_title>Remifentanil Versus Sufentanil for Intubation Condition Without Myorelaxant</brief_title>
  <acronym>REMIDENT</acronym>
  <official_title>Comparison of Intubation Conditions After Induction With Propofol Associated With a Dose of Remifentanil or Sufentanil in Surgical Tooth Extraction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is the comparison of intubation conditions after anesthetic induction
      bolus of propofol-sufentanil when compared to injection of propofol-remifentanil in patients
      undergoing surgery for tooth extraction.

      Intubation without myorelaxant with propofol and sufentanil is classic but less efficient
      than induction with curare on achieving perfect intubation conditions. The use of a protocol
      without curare is sometimes justified for short gestures or when you want to avoid allergia.
      Remifentanil often provides excellent intubation conditions without myorelaxant. However,
      remifentanil was never compared to sufentanil in terms of intubating conditions without
      muscle relaxant.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Scandinavian Scale of Intubation Conditions (from Viby-Mogensen). The comparison will be made on the percentage of obtaining excellent intubation conditions.</measure>
    <time_frame>This outcome measure is assessed at day 1 during the per-anesthetic period.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of patient with a decrease of over 20% in Mean Arterial Pressure (MAP) or Heart Rate (HR)</measure>
    <time_frame>This outcome measure is assessed at day 1 during the per-anesthesic period and the monitoring period in PACU.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>breath - hold time - time to extubation, time to Aldrete score of 10 in PostAnesthesia Care Unit (PACU)</measure>
    <time_frame>This outcome measure is assessed at day 1 during the per-anesthesic period and the monitoring period in PACU.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>difficult intubating scale (Adnet et al. Anesthesiology. 99)</measure>
    <time_frame>This outcome measure is assessed at day 1 during the per-anesthesic period and the monitoring period in PACU.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Anaesthetic Induction</condition>
  <arm_group>
    <arm_group_label>Remifentanyl- sufentanil placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 mg/kg of propofol combined with 3 µg/kg of remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sufentanil - remifentanyl placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 mg/kg of propofol combined with 0.3 mg/kg of sufentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanyl - sufentanil placebo</intervention_name>
    <description>Induction of general anesthesia with 3 mg/kg of propofol combined with 3 µg/kg of remifentanil and 10 ml of isotonic sodium chloride for the double blind. The trachea is then intubated after waiting the time of action of each product.</description>
    <arm_group_label>Remifentanyl- sufentanil placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil - remifentanyl placebo</intervention_name>
    <description>Induction of general anesthesia with 3 mg/kg of propofol combined with 0.3 mg/kg of sufentanil and 25 ml of isotonic sodium chloride for the double blind. The trachea is then intubated after waiting the time of action of each product.</description>
    <arm_group_label>Sufentanil - remifentanyl placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients 18 to 60 years

          -  American Society of Anesthesiology (ASA) 1 or 2

          -  scheduled for surgical tooth extraction under general anesthesia with intubation

          -  signed consent form

        Exclusion Criteria:

          -  criterion of difficult ventilation or intubation

          -  chronic alcoholism or opiate use

          -  beta-blockers or calcium channel blockers treatment

          -  allergy to paracetamol or ketoprofen

          -  patient under protection of justice
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine ROCHE-TISSOT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine ROCHE-TISSOT, MD</last_name>
    <phone>05 61 77 25 16</phone>
    <phone_ext>33</phone_ext>
    <email>roche.c@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital of Purpan</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine ROCHE-TISSOT, MD</last_name>
      <phone>05 61 77 25 16</phone>
      <phone_ext>33</phone_ext>
      <email>roche.c@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Franck BOUTAULT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Françoise FEDACOU, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent MINVILLE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura BRUNETEAU, Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Laxenaire MC. [Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996)]. Ann Fr Anesth Reanim. 1999 Aug;18(7):796-809. French.</citation>
    <PMID>10486634</PMID>
  </reference>
  <reference>
    <citation>Combes X, Andriamifidy L, Dufresne E, Suen P, Sauvat S, Scherrer E, Feiss P, Marty J, Duvaldestin P. Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort. Br J Anaesth. 2007 Aug;99(2):276-81. Epub 2007 Jun 15.</citation>
    <PMID>17573390</PMID>
  </reference>
  <reference>
    <citation>Alexander R, Olufolabi AJ, Booth J, El-Moalem HE, Glass PS. Dosing study of remifentanil and propofol for tracheal intubation without the use of muscle relaxants. Anaesthesia. 1999 Nov;54(11):1037-40.</citation>
    <PMID>10540091</PMID>
  </reference>
  <reference>
    <citation>Bouvet L, Stoian A, Rimmelé T, Allaouchiche B, Chassard D, Boselli E. Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol. Anaesthesia. 2009 Jul;64(7):719-26. doi: 10.1111/j.1365-2044.2009.05916.x.</citation>
    <PMID>19624626</PMID>
  </reference>
  <reference>
    <citation>Fujii Y, Itakura M. A comparison of pretreatment with fentanyl and lidocaine preceded by venous occlusion for reducing pain on injection of propofol: a prospective, randomized, double-blind, placebo-controlled study in adult Japanese surgical patients. Clin Ther. 2009 Oct;31(10):2107-12. doi: 10.1016/j.clinthera.2009.10.012.</citation>
    <PMID>19922881</PMID>
  </reference>
  <reference>
    <citation>Fattorini F, Romano R, Ciccaglioni A, Pascarella MA, Rocco A, Mariani V, Pietropaoli P. Effects of remifentanil on human heart electrical system. A transesophageal pacing electrophysiological study. Minerva Anestesiol. 2003 Sep;69(9):673-7, 677-9. English, Italian.</citation>
    <PMID>14564237</PMID>
  </reference>
  <reference>
    <citation>Maruyama K, Nishikawa Y, Nakagawa H, Ariyama J, Kitamura A, Hayashida M. Can intravenous atropine prevent bradycardia and hypotension during induction of total intravenous anesthesia with propofol and remifentanil? J Anesth. 2010 Apr;24(2):293-6. doi: 10.1007/s00540-009-0860-2. Epub 2010 Jan 26.</citation>
    <PMID>20101512</PMID>
  </reference>
  <reference>
    <citation>Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007 Aug;51(7):789-808.</citation>
    <PMID>17635389</PMID>
  </reference>
  <reference>
    <citation>Egan TD, Brock-Utne JG. Asystole after anesthesia induction with a fentanyl, propofol, and succinylcholine sequence. Anesth Analg. 1991 Dec;73(6):818-20.</citation>
    <PMID>1952185</PMID>
  </reference>
  <reference>
    <citation>Maryniak JK, Bishop VA. Sinus arrest after alfentanil. Br J Anaesth. 1987 Mar;59(3):390-1.</citation>
    <PMID>3103664</PMID>
  </reference>
  <reference>
    <citation>Starr NJ, Sethna DH, Estafanous FG. Bradycardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology. 1986 Apr;64(4):521-3.</citation>
    <PMID>2870669</PMID>
  </reference>
  <reference>
    <citation>Wang J, Winship S, Russell G. Induction of anaesthesia with sevoflurane and low-dose remifentanil: asystole following laryngoscopy. Br J Anaesth. 1998 Dec;81(6):994-5. No abstract available.</citation>
    <PMID>10211042</PMID>
  </reference>
  <reference>
    <citation>Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997 Dec;87(6):1290-7.</citation>
    <PMID>9416711</PMID>
  </reference>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 26, 2013</lastchanged_date>
  <firstreceived_date>July 15, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthetic induction</keyword>
  <keyword>Intubation conditions</keyword>
  <keyword>Tooth extraction</keyword>
  <keyword>Propofol</keyword>
  <keyword>Sufentanil</keyword>
  <keyword>Remifentanil</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
